Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Test Co-Pays Would Add To Labs’ Overhead; Firms Brace For Impact

This article was originally published in The Gray Sheet

Executive Summary

Diagnostic testing firms' profitability could suffer along with patient access to care if a laboratory diagnostic co-payment provision is included in pending Medicare reform legislation, stakeholders say
Advertisement

Related Content

Labs, Test Makers To Finance Committee: Say "No" To Medicare Co-Pay
Labs, Test Makers To Finance Committee: Say "No" To Medicare Co-Pay
Lab Co-Pay Provision Dropped From Medicare Package In Favor Of Freeze
Lab Co-Pay Provision Dropped From Medicare Package In Favor Of Freeze
Lab concerns with Medicare legislation
Advertisement
UsernamePublicRestriction

Register

MT019088

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel